NVIDIA
NVDA
Tesla
TSLA
Marvell Technology
MRVL
4
Palantir
PLTR
5
Alibaba
BABA
Berenberg Ups Sanofi Price Target Amid 'Highly Attractive' Valuation, Shareholder Alignment
Berenberg Bank Maintains Sanofi(SNY.US) With Buy Rating, Maintains Target Price $63
Berenberg Bank Reaffirms Their Buy Rating on Sanofi (SNYNF)
Press Release: Sanofi Successfully Prices EUR 1.5 Billion of Bond Issue
The Flu Season Was so Heavy That It May Have Pushed up Earnings for Some Stocks
$1.57 Trillion Immunotherapy Drugs Markets, 2020-2024 & 2025-2030 Featuring F. Hoffmann-La Roche, Merck, Eli Lily & Co, Pfizer, Novartis, Amgen, Sanofi, Johnson & Johnson, Bayer, Bristol Myers Squibb - ResearchAndMarkets.com
Deutsche Bank Remains a Hold on Sanofi (SNYNF)
Top Gap Ups and Downs on Monday: SNY, GFI, LI and More
Top HHS Spokesman Tom Corry Abrupty Resigns
Apogee Therapeutics' Investigational Atopic Dermatitis Potential Shows Strong Tolerability, Extended Half-Life in Early Trial
Is Sanofi (SNY) The Best Immunology Stock To Buy Now?
Sanofi and Teva Reveal Promising Duvakitug Study Results at ECCO 2025
Media Update: AAD: New Data Advance Sanofi's Scientific Leadership Across Innovative Treatments for Inflammatory Skin Diseases
Sanofi India Reports Strong Financial Results and Proposes Dividend
Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value
Novavax Stock Rises as Revenue Beat Estimates
Novavax Posts Q4 Revenue Beat Despite 80% Drop in Product Sales
FDA AdCom Meeting on Flu Vaccines Canceled
Sanofi's Sustained Revenue Growth Potential: Buy Rating Justified by Extended Amvuttra Royalties
CDC A(H5N1) Bird Flu Response Update February 26, 2025; Confirmed 3 Human Cases Of H5 Bird Flu In People Who Became Ill In 2025 - Website